CAR T-cell therapy is starting to enter the treatment conversations sooner with patients with multiple myeloma, according to ...

Panelists discuss how the MARIPOSA study findings demonstrated significant progression-free survival and overall survival ...

Anlotinib combined with immune checkpoint inhibitors may benefit patients with extensive-stage small cell lung cancer treated ...

Panelists discuss how both amivantamab plus lazertinib and osimertinib-based regimens show good central nervous system (CNS) ...

Planning for adverse effects early on helps patients prepare for what lies ahead, says Michelle Kirschner, MSN, RN, ACNP, ...

In TP53 wild-type advanced or recurrent endometrial cancer, selinexor improved multiple time-to-event outcomes vs placebo.

Formal communication could help ease the transition of care from specialized myeloma centers to community clinic, according ...

Q&A: Prioritizing QOL Important to Treating HR+, HER2- Metastatic Breast Cancer ...

Genomic Changes May Drive Sotorasib KRAS G12C+ Combo Resistance in CRC ...